vimarsana.com

StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. HC Wainwright reaffirmed a buy rating and issued a $9.00 price objective on shares […]

Related Keywords

Craig Hallum ,Susquehanna International Group ,News Ratings For Alimera Sciences Daily ,Alimera Sciences Trading ,Renaissance Technologies ,Hedge Funds Weigh In On Alimera Sciences ,Alimera Sciences Company Profile ,Securities Exchange Commission ,Alimera Sciences ,Alimera Sciences Inc ,Millennium Management ,Get Rating ,Alto Investors Lp Palo ,Exchange Commission ,International Group ,Caligan Partners ,Alimera Sciences Daily ,Nasdaq Alim ,Bsalim ,Medical ,Initiated Coverage ,Stocknews Com ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.